Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acute Disease × vosaroxin × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Myelodysplastic Syndromes 3 Leukemia, Myeloid, Acute 3 Neoplasms 2 Leukemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Diseases 1 Acute Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00607997 2017-06-28

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Sunesis Pharmaceuticals

Phase 2 Completed

113 enrolled 25 charts

MyeloidOther hematologic neoplasm

Acute Disease, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡